Orthoclone OKT3 Interactions
There are 166 drugs known to interact with Orthoclone OKT3 (muromonab-cd3), along with 4 disease interactions. Of the total drug interactions, 49 are major, 109 are moderate, and8 are minor.
- View all 166 medications that may interact with Orthoclone OKT3
- View Orthoclone OKT3 disease interactions (4)
Most frequently checked interactions
View interaction reports for Orthoclone OKT3 (muromonab-cd3) and the medicines listed below.
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adderall (amphetamine / dextroamphetamine)
- Adriamycin PFS (doxorubicin)
- Adriamycin RDF (doxorubicin)
- Advil (ibuprofen)
- Albuminar-5 (albumin human)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Avastin (bevacizumab)
- Banzel (rufinamide)
- Blincyto (blinatumomab)
- Doxil (doxorubicin liposomal)
- Effexor XR (venlafaxine)
- Enbrel (etanercept)
- Farydak (panobinostat)
- Imbruvica (ibrutinib)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Kevzara (sarilumab)
- Norvir (ritonavir)
- Ofev (nintedanib)
- Pomalyst (pomalidomide)
- progesterone
- Ravicti (glycerol phenylbutyrate)
- Sprycel (dasatinib)
- Stivarga (regorafenib)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir disoproxil)
- Thalomid (thalidomide)
- Votrient (pazopanib)
- Xanax (alprazolam)
Orthoclone OKT3 disease interactions
There are 4 disease interactions with Orthoclone OKT3 (muromonab-cd3) which include:
More about Orthoclone OKT3 (muromonab-cd3)
- Orthoclone OKT3 consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.